News
The outgoing chief executive of Novo Nordisk has revealed plans to ramp-up cost cutting 'efficiencies' across the business, ...
Bloomberg on MSN13h
Novo CFO: US Wegovy, Ozempic Prices to Keep FallingThe maker of Ozempic and Wegovy obesity drugs said some of the prices could come down, as President Trump called for ...
Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...
1h
Investor's Business Daily on MSNNovo Nordisk Slumps As 'Unlawful' Knockoffs Pressure Wegovy, OzempicNovo NordiskNVO stock slumped Wednesday after the drugmaker said it expects continued competition this year from "unsafe and ...
Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish ...
Once aimed at diabetes patients, drugs like Ozempic are famous for bringing about rapid weight loss. But the injections often ...
Novo Nordisk (NVO) offered investors an update about ongoing cost-cutting efforts as copycat weight-loss drugs weigh on sales ...
Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition ...
13h
inews.co.uk on MSNI was a Noughties magazine editor - this era is much worse for womenFrom weight-loss drugs to Botox, women are becoming more critical of their appearance in an attempt to keep up with social ...
The number of people taking weight-loss injections is exploding. With more and more men going “on the needle”, here’s what ...
12h
GlobalData on MSNNovo Nordisk files 14 new lawsuits against unapproved semaglutide drugsNovo Nordisk has announced the filing of 14 new lawsuits against the sale of unapproved compounded drugs claiming to contain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results